Teva Says FTC Can't Draw It Into Pay-For-Delay Case
Generic drug giant Teva Pharmaceutical Industries Ltd. on Wednesday urged a Pennsylvania federal judge to deny a bid from the Federal Trade Commission to add the company to its antitrust pay-for-delay...To view the full article, register now.
Already a subscriber? Click here to view full article